97 related articles for article (PubMed ID: 6205771)
1. Histamine-releasing activity. V. Characterization and purification using high-performance liquid chromatography.
Lett-Brown MA; Thueson DO; Plank DE; Duffy L; Grant JA
Cell Immunol; 1984 Sep; 87(2):445-51. PubMed ID: 6205771
[TBL] [Abstract][Full Text] [Related]
2. Histamine-releasing activity. IV. Molecular heterogeneity of the activity from stimulated human thoracic duct lymphocytes.
Lett-Brown MA; Thueson DO; Plank DE; Langford MP; Grant JA
Cell Immunol; 1984 Sep; 87(2):434-44. PubMed ID: 6205770
[TBL] [Abstract][Full Text] [Related]
3. Purification and further characterization of human mononuclear cell histamine-releasing factor.
Baeza ML; Reddigari S; Haak-Frendscho M; Kaplan AP
J Clin Invest; 1989 Apr; 83(4):1204-10. PubMed ID: 2467921
[TBL] [Abstract][Full Text] [Related]
4. Histamine releasing activity (HRA) produced by leukocytes co-cultured with tumor cells.
Langford MP; Lett-Brown MA; Stanton GJ; Grant JA
Immunol Invest; 1987 Apr; 16(2):129-38. PubMed ID: 2442099
[TBL] [Abstract][Full Text] [Related]
5. A histamine-releasing factor from activated human mononuclear cells.
Kaplan AP; Haak-Frendscho M; Fauci A; Dinarello C; Halbert E
J Immunol; 1985 Sep; 135(3):2027-32. PubMed ID: 2410512
[TBL] [Abstract][Full Text] [Related]
6. Preparative two-step purification of human IL-2 by HPLC and hydrophobic affinity chromatography.
Godard A; Naulet J; Peyrat MA; Vie H; Moreau JF; Bignon JD; Soulillou JP
J Immunol Methods; 1984 May; 70(2):233-44. PubMed ID: 6609996
[TBL] [Abstract][Full Text] [Related]
7. Production of a histamine-releasing lymphokine by antigen- or mitogen-stimulated human peripheral T cells.
Sedgwick JD; Holt PG; Turner KJ
Clin Exp Immunol; 1981 Aug; 45(2):409-18. PubMed ID: 6172226
[TBL] [Abstract][Full Text] [Related]
8. Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes.
Yoshimura T; Robinson EA; Tanaka S; Appella E; Leonard EJ
J Immunol; 1989 Mar; 142(6):1956-62. PubMed ID: 2921521
[TBL] [Abstract][Full Text] [Related]
9. Assessment of histamine release and kinin formation in man: identification of kinin degradation products and characterization of a lymphocyte-dependent histamine releasing factor.
Kaplan AP; Sheikh I; Frendscho MH
Int Arch Allergy Appl Immunol; 1985; 77(1-2):64-8. PubMed ID: 2409028
[TBL] [Abstract][Full Text] [Related]
10. Suppressor cell-inducing factor: a new lymphokine secreted by a natural suppressor cell line with natural cytotoxic activity. I. Purification to apparent homogeneity and initial characterization of suppressor cell-inducing factor.
Almawi WY; Dolphin PJ; Thies RL; McMaster WR; Levy JG; Pope BL
J Immunol; 1988 Oct; 141(8):2529-35. PubMed ID: 3171178
[TBL] [Abstract][Full Text] [Related]
11. Partial purification and characterization of chicken interleukin-2.
Myers TJ; Lillehoj HS; Fetterer RH
Vet Immunol Immunopathol; 1992 Oct; 34(1-2):97-114. PubMed ID: 1441231
[TBL] [Abstract][Full Text] [Related]
12. Histamine-releasing activity (HRA). I. Production by mitogen- or antigen-stimulated human mononuclear cells.
Thueson DO; Speck LS; Lett-Brown MA; Grant JA
J Immunol; 1979 Aug; 123(2):626-32. PubMed ID: 88479
[TBL] [Abstract][Full Text] [Related]
13. Characterization of human lymphocyte derived chemotactic factors for mononuclear phagocytes--II. Chemical characterization.
Ramb C; McEntire JE; Sorg C
Mol Immunol; 1983 Mar; 20(3):325-32. PubMed ID: 6865954
[TBL] [Abstract][Full Text] [Related]
14. Purification of human interleukin 1 by high-performance liquid chromatography.
Köck A; Luger TA
J Chromatogr; 1984 Jul; 296():293-300. PubMed ID: 6332821
[TBL] [Abstract][Full Text] [Related]
15. Purification of oestrogen synthetase by high-performance liquid chromatography. Two membrane-bound enzymes from the human placenta.
Muto N; Tan L
J Chromatogr; 1985 Jun; 326():137-46. PubMed ID: 3928664
[TBL] [Abstract][Full Text] [Related]
16. Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors.
Liu MC; Proud D; Lichtenstein LM; MacGlashan DW; Schleimer RP; Adkinson NF; Kagey-Sobotka A; Schulman ES; Plaut M
J Immunol; 1986 Apr; 136(7):2588-95. PubMed ID: 2419444
[TBL] [Abstract][Full Text] [Related]
17. Neutrophils and mast cells. Comparison of neutrophil-derived histamine-releasing activity with other histamine-releasing factors.
White MV; Kaplan AP; Haak-Frendscho M; Kaliner M
J Immunol; 1988 Nov; 141(10):3575-83. PubMed ID: 2460539
[TBL] [Abstract][Full Text] [Related]
18. Purification and initial characterization of the lymphokine soluble immune response suppressor.
Aune TM; Webb DR; Pierce CW
J Immunol; 1983 Dec; 131(6):2848-52. PubMed ID: 6417233
[TBL] [Abstract][Full Text] [Related]
19. Purification of human B cell growth factor.
Mehta SR; Conrad D; Sandler R; Morgan J; Montagna R; Maizel AL
J Immunol; 1985 Nov; 135(5):3298-302. PubMed ID: 3876383
[TBL] [Abstract][Full Text] [Related]
20. Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III.
Baeza ML; Reddigari SR; Kornfeld D; Ramani N; Smith EM; Hossler PA; Fischer T; Castor CW; Gorevic PG; Kaplan AP
J Clin Invest; 1990 May; 85(5):1516-21. PubMed ID: 1692035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
